NEW YORK (GenomeWeb) – 23andMe and Pfizer said today they will launch a joint research project to study genetic factors involved in the onset, progression, severity, and response to treatments for inflammatory bowel disease.
Already have a GenomeWeb or 360Dx account?Login Now.
An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.
Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.
The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.
In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.
Proximity ligation technology generates multi-dimensional next-generation sequencing data that is proving to solve unmet needs in genomic research.
This webinar will discuss how an algorithm-driven synthetic biology system can enable engineering of biological systems for a range of applications.